StockWatch
·

NATCO PHARMA LTD. Q4 FY26 Results

NATCOPHARMQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue739.1014.2%39.5%
Total Income816.9015.8%36.5%
Expenditure672.8023.6%13.9%
PBT144.1010.6%71.5%
Net Profit269.0077.8%33.7%
OPM17.26%7.26pp27.63pp
NPM32.93%11.48pp1.39pp
EPS14.9676.8%34.1%
View full financials

Informational and educational content only. Not investment advice.